Concepedia

Andrew D. Malewicz

AD

Statistics

Publications

1

Citations

134

H-Index

1

Active since

2006

Affiliations

Progenics Pharmaceuticals (United States)(Current)

Andrew D. Malewicz is an author at Progenics Pharmaceuticals (United States) specializing in antibody-drug conjugate elimination, antibody-drug conjugate therapy, and prostate cancer.

Publications per year

2006–2006

1

Publications

1

Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen

Dangshe Ma, Christine Hopf, Andrew D. Malewicz et al. · Clinical Cancer Research · 2006 · 134 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1